Valuation Laboratorio Farmaceutico Erfo S.p.A.

Stocks

Market Closed - Borsa Italiana 11:45:00 2026-09-02 EDT			5-day change	1st Jan Change
1.140 ^EUR	+0.44%		0.00%	-22.45%

08-31	Milan in the pink at the open, oil stocks lead the MIB	AN
08-31	Futures weak; Brent higher after US-Iran attacks	AN

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025
Market Cap ¹	18.27	11.79	10.8	12.53
Change	-	-35.47%	-8.4%	16.03%
Enterprise Value (EV) ¹	17.38	11.41	10.81	12.83
Change	-	-34.34%	-5.31%	18.7%
P/E	25.5x	19.1x	30.8x	17x
PBR	2.33x	1.43x	1.44x	1.57x
PEG	-0.3x	-1.4x	-0.8x	0x
Capitalization / Revenue	3.87x	1.99x	1.79x	1.29x
EV / Revenue	3.68x	1.92x	1.79x	1.32x
EV / EBITDA	11.8x	8.02x	10.1x	7x
EV / EBIT	17.6x	13.6x	20.6x	12x
EV / FCF	-	-	-	-
FCF Yield	-	-	-	-
Dividend per Share ²	-	0.06	-	-
Rate of return	-	4.58%	-	-
EPS ²	0.0796	0.0686	0.0411	0.0865
Distribution rate	-	87.4%	-	-
Net sales ¹	4.719	5.932	6.032	9.732
EBITDA ¹	1.474	1.423	1.065	1.832
EBIT ¹	0.987	0.8367	0.5239	1.066
Net income ¹	0.7161	0.5903	0.3528	0.737
Net Debt ¹	-0.8895	-0.3784	0.005767	0.2954
Reference price ²	2.030	1.310	1.265	1.470
Nbr of stocks (in thousands)	9,000	9,000	8,537	8,524
Announcement Date	4/12/23	5/8/24	4/14/25	4/12/26

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LABORATORIO FARMACEUTICO ERFO S.P.A.	-	-	-	-	11.21M
ELI LILLY AND COMPANY	33.02x	11.99x	24.3x	0.6%	1,034B
JOHNSON & JOHNSON	29.7x	-	-	1.98%	654B
ABBVIE INC.	33.18x	7.69x	15.99x	2.64%	459B
ROCHE HOLDING AG	19.36x	4.61x	11.42x	2.88%	343B
NOVARTIS AG	22.91x	5.89x	14.6x	2.71%	307B
ASTRAZENECA PLC	20.82x	4.27x	12.21x	2.06%	251B
AMGEN INC.	27.71x	7.15x	12.7x	2.3%	237B
NOVO NORDISK A/S	13.18x	4.74x	9.88x	3.82%	202B
GILEAD SCIENCES, INC.	-45.81x	6.6x	25.78x	2.2%	186B
Average	17.12x	6.62x	15.86x	2.35%	367.16B
Weighted average by Cap.	24.07x	8.04x	17.80x	1.96%